<DOC>
	<DOCNO>NCT02596360</DOCNO>
	<brief_summary>The aim study ass anti-hyperalgesic effect dextromethorphan healthy volunteer compare placebo .</brief_summary>
	<brief_title>Dextromethorphan Effect Central Sensitization Pain Healthy Volunteers</brief_title>
	<detailed_description>This cross-over group , double-blind , randomize clinical trial healthy volunteer compare dextromethorphan inactive control freeze-induced hyperalgesia , experimental pain , diffuse noxious inhibitory control ( DNIC ) , pupillary reaction reaction time . The influence CYP3A4 MDR1 polymorphism dextromethorphan analgesic efficacy measure . The study design divide two study sequence subject participates two study sequence receive two treatment ( dextromethorphan placebo ) . Each study sequence consist 3 assessment day ( Day -1 , Day 0 = first treatment administration Day 1 ) .</detailed_description>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<criteria>Healthy male volunteer Aged 18 45 year CYP2D6 Extensive Intermediate metabolizers Body mass index ( BMI ) 19 30 kg/m2 Systolic blood pressure 100 150 mmHg , diastolic blood pressure 50 90 mmHg , heart rate 45 90 beat per minute Without treatment 7 day inclusion specially use analgesic antiinflammatory drug Cooperation understand enough conform study obligation Having give free inform write consent Affiliated French Social Security Inscription acceptation inscription national register volunteer involve trial . Hypersensitivity active substance excipients Lactose intolerance Hypertension History stroke Severe heart failure Severe hepatic impairment Shortness breath Congenital galactosemia , glucosegalactose malabsorption , lactase deficiency Association linezolid Preexistence history peripheral neuropathy due cause different neurotoxic chemotherapy Diabetes ( type I II ) CYP2D6 Poor Ultrarapid metabolizers AST , ALT , total bilirubin twice average Dextromethorphan intake 7 day inclusion Medical surgical history incompatible study Disease progression inclusion Excessive consumption alcohol ( &gt; 50g/day ) , tobacco ( â‰¥ 10 cigarettes/day ) , coffee , tea drink caffeine ( equivalent 4 cup day ) addiction drug Subject lack concentration test train low test result reproducibility Subject meet selection criterion ability discriminate sensation noxious stimulus psychometric test Subject exclusion period , total allowable compensation exceed Subject undergoing measure legal protection ( guardianship , supervision</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Antinociception</keyword>
	<keyword>Freeze-induced hyperalgesia model</keyword>
	<keyword>Dextromethorphan</keyword>
	<keyword>NMDA-receptors</keyword>
	<keyword>Pharmacogenetic</keyword>
	<keyword>CYP3A4 gene</keyword>
	<keyword>MDR1 gene</keyword>
</DOC>